Combined synopsis and solicitation
COVID-19 Pediatric Vaccine
75D30124R72939
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Pharmaceutical Preparation Manufacturing.
Response deadline
April 18, 2024 at 4:30 PM EDT
Closed 928 days ago. Posted April 15, 2024, first published April 3, 2024. Scheduled to archive May 3, 2024.
Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities
This one closed in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 4 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 10 daysNov 12
Description
As published on SAM.gov.
The Centers for Disease Control and Prevention (CDC) is seeking to award one or more indefinite delivery indefinite quantity (IDIQ) contracts for the purchase of standard pediatric vaccines.
Item Description and Quantities Covid-19 Vaccine - Pediatric (Ages 0-18 years) Maximum ordering quantity: Up to 30 million doses Minimum ordering quantity: 100 doses Minimum order size: 100 doses Federal Excise Tax: $0.75 per dose Ordering period: One year from date of award The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace.
In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine- eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s.
The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Offers shall be submitted by 4:30PM Easter time (EST) on April 17, 2024. Offers shall be submitted electronically (via email) in Microsoft Word and/or Microsoft Excel files to Matthew Nelson, Contract Specialist, lza0@cdc.gov and David Dombeck, Contracting Officer, vwj8@cdc.gov. Offers shall reference RFP No. 75D30124R72939.
This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15. The solicitation and any amendments issued will be posted on www.SAM.gov when issued. No hard copies of the solicitation and amendments will be mailed. Inquiries about the solicitation shall be submitted to Matthew Nelson, Contract Specialist, at lza0@cdc.gov.
The deadline for questions to be submitted prior to the due date for proposals is April 12, 2024 at 4:30PM EST. The Government may not answer questions received after this date.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 3, 2024
Combined synopsis and solicitation
Due April 17, 2024 at 4:30 PM EDT. SAM.gov, notice 9e1c48d72e5a4d5d8fe52bd964102f92
April 11, 2024
Combined synopsis and solicitation
Due April 18, 2024 at 4:30 PM EDT. SAM.gov, notice 4601d67180154e819aa396d5a0f431d7
April 15, 2024
Combined synopsis and solicitation
Due April 18, 2024 at 4:30 PM EDT. SAM.gov, notice eb4eae55bac34468a01b2560f35621db
Points of contact
- Matthew Nelsonmnelson2@cdc.gov14044984311
- David Dombeckvwj8@cdc.gov7704882695